These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
997 related items for PubMed ID: 24327265
1. Lipid-lowering agents for nephrotic syndrome. Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L. Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265 [Abstract] [Full Text] [Related]
2. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF. Cochrane Database Syst Rev; 2014 Jan 28; 2014(1):CD005019. PubMed ID: 24470059 [Abstract] [Full Text] [Related]
3. Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia. Izquierdo-Palomares JM, Fernandez-Tabera JM, Plana MN, Añino Alba A, Gómez Álvarez P, Fernandez-Esteban I, Saiz LC, Martin-Carrillo P, Pinar López Ó. Cochrane Database Syst Rev; 2016 Nov 26; 11(11):CD009462. PubMed ID: 27888640 [Abstract] [Full Text] [Related]
4. Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E. ; 2016 08 26. PubMed ID: 27559556 [Abstract] [Full Text] [Related]
5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF. Cochrane Database Syst Rev; 2014 May 31; (5):CD007784. PubMed ID: 24880031 [Abstract] [Full Text] [Related]
6. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events. Zhan S, Tang M, Liu F, Xia P, Shu M, Wu X. Cochrane Database Syst Rev; 2018 Nov 19; 11(11):CD012502. PubMed ID: 30480766 [Abstract] [Full Text] [Related]
7. HMG CoA reductase inhibitors (statins) for dialysis patients. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF. Cochrane Database Syst Rev; 2013 Sep 11; 2013(9):CD004289. PubMed ID: 24022428 [Abstract] [Full Text] [Related]
8. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Liu ID, Willis NS, Craig JC, Hodson EM. Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142 [Abstract] [Full Text] [Related]
9. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2009 Apr 15; (2):CD005019. PubMed ID: 19370615 [Abstract] [Full Text] [Related]
10. HMG CoA reductase inhibitors (statins) for dialysis patients. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2009 Apr 15; (2):CD004289. PubMed ID: 19370598 [Abstract] [Full Text] [Related]
11. HMG CoA reductase inhibitors (statins) for dialysis patients. Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2009 Jul 08; (3):CD004289. PubMed ID: 19588351 [Abstract] [Full Text] [Related]
12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF. Cochrane Database Syst Rev; 2009 Apr 15; (2):CD007784. PubMed ID: 19370693 [Abstract] [Full Text] [Related]
13. Fibrates for primary prevention of cardiovascular disease events. Jakob T, Nordmann AJ, Schandelmaier S, Ferreira-González I, Briel M. Cochrane Database Syst Rev; 2016 Nov 16; 11(11):CD009753. PubMed ID: 27849333 [Abstract] [Full Text] [Related]
14. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Hodson EM, Wong SC, Willis NS, Craig JC. Cochrane Database Syst Rev; 2016 Oct 11; 10(10):CD003594. PubMed ID: 27726125 [Abstract] [Full Text] [Related]
15. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Lewicki M, Ng I, Schneider AG. Cochrane Database Syst Rev; 2015 Mar 11; 2015(3):CD010480. PubMed ID: 25758322 [Abstract] [Full Text] [Related]
17. HMG CoA reductase inhibitors (statins) for dialysis patients. Navaneethan SD, Shrivastava R. Cochrane Database Syst Rev; 2004 Oct 18; (4):CD004289. PubMed ID: 15495097 [Abstract] [Full Text] [Related]
18. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome. Chen Y, Gong Z, Chen X, Tang L, Zhao X, Yuan Q, Cai G. Cochrane Database Syst Rev; 2013 Aug 11; (8):CD008568. PubMed ID: 23934958 [Abstract] [Full Text] [Related]
19. Immunosuppressive agents for treating IgA nephropathy. Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF. Cochrane Database Syst Rev; 2015 Aug 03; (8):CD003965. PubMed ID: 26235292 [Abstract] [Full Text] [Related]
20. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Eslami L, Merat S, Malekzadeh R, Nasseri-Moghaddam S, Aramin H. Cochrane Database Syst Rev; 2013 Dec 27; (12):CD008623. PubMed ID: 24374462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]